Role of neuroinflammation in hypertension-induced brain amyloid pathology
Role of neuroinflammation in hypertension-induced brain amyloid pathology
复制标题
DOI:
10.1016/j.neurobiolaging.2010.08.013
复制
发表时间:
2012-01-01
影响因子:
4.2
通讯作者:
Minghetti, Luisa
中科院分区:
文献类型:
--
作者:
Carnevale, Daniela;Mascio, Giada;Minghetti, Luisa
Hypertension and sporadic Alzheimer's disease (AD) have been associated but clear pathophysiological links have not yet been demonstrated. Hypertension and AD share inflammation as a pathophysiological trait. Thus, we explored if modulating neuroinflammation could influence hypertension-induced beta-amyloid (A beta) deposition.Possible interactions among hypertension, inflammation and A beta-deposition were studied in hypertensive mice with transverse aortic coarctation (TAC). Given that brain A beta deposits are detectable as early as 4 weeks after TAC, brain pathology was analyzed in 3-week TAC mice, before A beta deposition, and at a later time (8-week TAC mice).Microglial activation and interleukin (IL)-1 beta upregulation were already found in 3-week TAC mice. At a later time, along with evident A beta deposition, microglia was still activated. Finally, immune system stimulation (LPS) or inhibition (ibuprofen), strategies described to positively or negatively modulate neuroinflammation, differently affected A beta deposition.We demonstrate that hypertension per se triggers neuroinflammation before A beta deposition. The finding that only immune system activation, but not its inhibition, strongly reduced amyloid burden suggests that stimulating inflammation in the appropriate time window may represent a promising strategy to limit vascular-triggered AD-pathology. (C) 2012 Elsevier Inc. All rights reserved.